A Randomized, Double-Blind, PlaceboControlled, Multiple Ascending Dose Pharmacokinetics(PK), Pharmacodynamics(PD), and Tolerability of LP352 in Healthy Subjects

Authors
Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: 59a123ba0098a97bdd5373e8dc5bf43e7bcf1746
First added on: Feb 14, 2025